NWAM LLC’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,564	Closed	-$221K	–	577
2023 Q3	$221K	Sell	5,564 -2,557	-31%	-$108K	0.02%	454
2023 Q2	$333K	Buy	+8,121	New	+$335K	0.03%	393
2023 Q1	–	Sell	-11,962	Closed	-$490K	–	559
2022 Q4	$490K	Buy	11,962 +340	+3%	+$14.2K	0.04%	314
2022 Q3	$467K	Sell	11,622 -271	-2%	-$11.6K	0.04%	303
2022 Q2	$500K	Buy	11,893 +145	+1%	+$6.08K	0.05%	302
2022 Q1	$532K	Buy	11,748 +122	+1%	+$5.36K	0.04%	318
2021 Q4	$537K	Buy	11,626 +769	+7%	+$36.4K	0.04%	318
2021 Q3	$515K	Sell	10,857 -20	-0.2%	-$994	0.05%	317
2021 Q2	$563K	Sell	10,877 -5,451	-33%	-$274K	0.05%	290
2021 Q1	$822K	Sell	16,328 -106	-0.6%	-$5.65K	0.08%	229
2020 Q4	$856K	Sell	16,434 -82	-0.5%	-$3.92K	0.1%	193
2020 Q3	$718K	Buy	16,516 +1,165	+8%	+$51K	0.12%	147
2020 Q2	$660K	Buy	15,351 +62	+0.4%	+$2.56K	0.09%	204
2020 Q1	$551	Sell	15,289 -439	-3%	-$18.7K	0.01%	217
2019 Q4	$718K	Buy	15,728 +633	+4%	+$25.1K	0.12%	174
2019 Q3	$537K	Sell	15,095 -1,909	-11%	-$71K	0.1%	194
2019 Q2	$677K	Buy	17,004 +749	+5%	+$29.5K	0.14%	155
2019 Q1	$676K	Buy	+16,255	New	+$661K	0.15%	152
2018 Q4	–	Sell	-4,841	Closed	-$235K	–	362
2018 Q3	$235K	Buy	+4,841	New	+$229K	0.05%	295